在高剂量吸入氧化治疗中甲红蛋白形成的预测因素:一项回顾性队列研究
Talisa Bühl1, Stefano Cenci1, Stefano Gianni1
1Department of Anesthesia, Critical Care and Pain Medicine, Massachusetts General Hospital, 55 Fruit Street, Boston, MA, 02114, USA; Harvard Medical School, 25 Shattuck St, Boston, MA, 02115, USA.
Nitric oxide : biology and chemistry
|November 22, 2025
概括
高剂量吸入的氧化 (iNO) 高达300ppm是安全的,耐受性良好. 甲血球蛋白的形成取决于iNO剂量和患者因素,指导个性化的iNO治疗.
科学领域:
- 医学研究 医学研究
- 肺部病理学 肺部病理学
- 药理学 药理学是指药理学的学科.
背景情况:
- 高剂量吸入的氧化 (iNO) 显示出抗菌潜力.
- 升高的iNO可以增加甲血球蛋白 (MetHb),影响氧气运输.
- 了解MetHb预测因子对于安全的iNO治疗至关重要.
研究的目的:
- 在高剂量iNO治疗期间识别影响甲血球蛋白形成的因素.
- 评估不同人群中高剂量iNO的安全性和耐受性.
主要方法:
- 追溯分析了71个人的660个高剂量iNO治疗.
- 包括健康的志愿者和患有COVID-19肺炎的患者 (孕妇和非孕妇).
- 混合效应建模分析了MetHb预测器.
主要成果:
- 较高的iNO度与增加的MetHb.相关.
- COVID-19肺炎,年龄较大,基线较高的MetHb和呼吸速率与MetHb相反相关.
- 没有发现性别,种族或血红蛋白的显著关联;没有观察到二氧化和全身毒性.
结论:
- 高剂量的iNO (高达300 ppm) 在各种患者群体中是安全的.
- MetHb形成受到iNO剂量和个体生理因素的影响.
- 这些发现支持个性化的iNO交付策略.
更多相关视频
08:23Chemiluminescence-based Assays for Detection of Nitric Oxide and its Derivatives from Autoxidation and Nitrosated Compounds
Published on: February 16, 2022
4.7K
08:44Author Spotlight: Integrating Alveolar-Capillary Reserve Measurements in Exercise Adaptation and Therapeutic Strategies
Published on: February 2, 2024
1.2K
相关概念视频
01:19Respiratory Assessment: Purpose and Indications
1.7K
Respiratory assessment is a cornerstone of nursing assessments, crucial for the early detection of patient deterioration. This evaluation transcends routine procedures, representing a critical skill nurses must master to ensure optimal patient care.
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
1.7K
01:21Acute Respiratory Failure-II
992
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
992